# QUBIS Innovation Fund

> QUBIS Innovation Fund is a VC fund in Belfast backing Biotechnology and Diabetes. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Belfast, United Kingdom
- Total investments: 5
- Last investment: Dec 2022
- Lead investor: 20%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/qubis-ltd-9a846067
- X (Twitter): https://twitter.com/qubisltd
- Website: https://www.qubis.co.uk/qubis-innovation-fund

QUBIS Innovation Fund is a VC fund in Belfast focused on Biotechnology and Diabetes. QUBIS is the commercialisation arm of Queen’s University, Belfast. Formed in 1984 it has a long and strong track–record in creating new technology start–ups, and otherwise helping commercialise leading–edge technology from the Queen’s research base.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 60% |
| Diabetes | 1 | 20% |
| Biopharma | 1 | 20% |
| Electronics | 1 | 20% |
| Health Care | 1 | 20% |

10 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Phlux Technology | Phlux is a photonics company developing innovative light detector and imaging systems. Spun out from the University of Sheffield in September 2020, Phlux is developing high performance infrared sensors for LIDAR, fibre sensing and imaging systems. | $4.9M | Seed | Dec 07, 2022 |  |
| AMPLY Discovery | AMPLY Discovery is to develop new biological molecules for anti-infective health and nutrition applications in animal and human health. | $1M | Seed | Sep 21, 2022 |  |
| Transdermal Diagnostics | Transdermal Diagnostics is a technology platform to improve the prevention, diagnosis, and management of chronic conditions with diabetes. | $920.9K | Seed | Sep 06, 2022 |  |
| ŌGI Bio | ŌGI Bio is a newly formed start-up company from The University of Edinburgh with the mission to revolutionize the way that microbes are grown and managed. | $1.2M | Seed | May 16, 2022 |  |
| Aramune Technologies | Aramune Technologies is developing natural, plant derived feed materials which can be mixed with standard animal feeds to replace antimicrobial agents and promote growth. | $1.1M | Seed | Feb 27, 2022 |  |

5 of 5 investments shown.

## Co-investors
- [Co-FundNI](https://shizune.co/investors/profile/co-fundni) — VC Fund, 2 deals together
- [Foresight Williams](https://shizune.co/investors/profile/the-foresight-williams-technology-eis-fund) — VC Fund, 2 deals together
- [Apollo Informal Investment](https://shizune.co/investors/profile/apollo-informal-investment) — VC Fund, 1 deal together
- [Bristol Private Equity Club](https://shizune.co/investors/profile/bristol-private-equity-club) — VC Fund, 1 deal together
- [Empirical Ventures](https://shizune.co/investors/profile/empirical-ventures) — VC Fund, 1 deal together
- [HBAN](https://shizune.co/investors/profile/halo-business-angel-network) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does QUBIS Innovation Fund invest in?

QUBIS Innovation Fund invests primarily in Biotechnology, Diabetes and Biopharma startups, most often at Seed stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did QUBIS Innovation Fund last invest?

The most recent investment recorded for QUBIS Innovation Fund closed in Dec 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co